AlphaYou
Overview
Key stats
Fundamentals Sep 12- Open
- $45.11
- 52-wk high
- $105.65
- High
- $46.27
- 52-wk low
- $42.20
- Low
- $44.89
- Prev close
- $44.98
- Mkt cap
- $62.29B
- P/E
- 17.5x
- Volume
- 17.98M
- Fwd P/E
- 12.7x
- Beta
- 0.57
- P/S
- 3.0x
- P/B
- 2.5x
- Profit margin
- +17.5%
- Op margin
- +22.9%
- ROE
- +15.3%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net buying.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 3.6% above what analysts expected.
Earnings per share
$0.83 expected
Revenue
No comparable estimate
Reports Oct 28, 2026, in 45 days
EPS expected
$0.58 to $0.84
Revenue expected
23 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
What the company said
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $5.07B | $5.29B | $5.20B | $5.44B |
| Cost of what it sold | $1.52B | $1.35B | $1.59B | $1.59B |
| Gross profit | $3.54B | $3.94B | $3.61B | $3.85B |
| What it spent | ||||
| Research and development | $514.0M | $569.0M | $516.0M | $554.0M |
| Sales and admin | $1.74B | $1.83B | $1.78B | $1.80B |
| Other operating costs | $237.0M | $328.0M | $244.0M | $313.0M |
| Total operating expenses | $2.49B | $2.73B | $2.54B | $2.67B |
| What was left | ||||
| Operating profit | $1.05B | $1.21B | $1.07B | $1.18B |
| Interest on debt | $87.0M | $90.0M | $90.0M | $96.0M |
| Profit before tax | $939.0M | $700.0M | $1.16B | $1.06B |
| Tax | $183.0M | $31.0M | -$176.0M | $155.0M |
| Net profit | $755.0M | $668.0M | $1.34B | $907.0M |
| EBITDA | $1.37B | $1.16B | $1.60B | $1.39B |
Technicals
Price structure
This stock is under pressure, and looks oversold after a sharp drop.
Trend
Under pressure
0 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
Tone of tracked coverage
J&J Opens Door to PFA Acquisitions After Internal Focus
NeutralSep 11Elevance Health Inc Stock (ELV) Moved Up by 5.50% on Sep 10: Drivers Behind the Movement
NeutralSep 10Stryker stock falls on slower peripheral vascular, hip sales
NeutralSep 10Abbott Spinal Cord Stimulator Explant Surgery Required After Device Failure: Lawsuit
BearishSep 10ShinyHunters expose 6.4M in attack on medical supplier McKesson
BearishSep 10Boston Scientific left nursing its bottom line after cyberattack
BearishSep 8Novartis and Boston Scientific Slide, Intel Price Hikes | Stock Movers
BearishSep 8Boston Scientific Warns On Earnings After Cyberattack
BearishSep 8
Macro
33 macro signals shaping BSX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results